Editorial: Advances in evaluation and management of hair loss disorders

Editorial: Advances in evaluation and management of hair loss disorders

Bibliographic Details
Main Author:	Manuel Valdebran
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Medicine
Subjects:	alopecia areata JAK inhibitor tofacitinib corticosteroids hair loss
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1131286/full

Similar Items

An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
by: Rachel Berbert Ferreira, et al.
Published: (2019-12-01)

Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
by: Misaki Kinoshita-Ise, et al.
Published: (2023-05-01)

Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
by: Md Mehedi Hossain, et al.
Published: (2024-04-01)

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023-11-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020-05-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)

Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
by: Leah Alexandra Johnston, BSc, MD, et al.
Published: (2023-05-01)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)

A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
by: Liwen Xu, et al.
Published: (2017-07-01)

Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
by: Dongfan Wei, et al.
Published: (2023-04-01)

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
by: Wenxin Zhang, et al.
Published: (2022-06-01)

Tofacitinib in a Recalcitrant Case of Alopecia Areata
by: Mansi Pithadia, et al.
Published: (2022-12-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
by: Georgio Chidiac, MD, et al.
Published: (2022-09-01)

Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
by: Alfred Ammoury, et al.
Published: (2023-06-01)

Trichoscopy for the Hair Transplant Surgeon—Assessing for Mimickers of Androgenetic Alopecia and Preoperative Evaluation of Donor Site Area
by: Naiem T. Issa, et al.
Published: (2021-10-01)

Pigmented vellus and upright regrowing hairs as the only predictive trichoscopic markers of hair regrowth in alopecia totalis and universalis
by: Anna Waśkiel-Burnat, et al.
Published: (2019-06-01)

Hair Loss after Varicella Zoster Virus Infection
by: Lara El Hayderi, et al.
Published: (2013-02-01)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016-04-01)

Short-term efficacy and safety of tofacitinib in the treatment of alopecia areata
by: Zuyan WANG, et al.
Published: (2024-02-01)

Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis
by: Yi Chen, et al.
Published: (2022-11-01)

Complete regrowth of hair following scalp tattooing in a patient with alopecia universalis
by: Amanda Ramnot, DO, et al.
Published: (2023-01-01)

Clinical response to oral tofacitinib in pediatric patients with alopecia areata
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

The use of minoxidil in diseases associated with hair loss
by: Alina Graczyk, et al.
Published: (2023-04-01)

COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
by: Arish Babadjouni, MS, et al.
Published: (2022-11-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023-01-01)

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
by: Diamant Thaçi, et al.
Published: (2023-09-01)

Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia
by: Jessica Maloh, et al.
Published: (2023-01-01)

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01)

“i hair”: A prognostic marker in alopecia areata & trichotillomania
by: Subrata Malakar, et al.
Published: (2017-01-01)

Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
by: Ji Su Lee, et al.
Published: (2018-11-01)

CORTICOSTEROID AS TREATMENT OF ALOPECIA AREATA
by: Ni Putu Junika Putri, et al.
Published: (2013-04-01)

Efficacy of Trichloroacetic Acid in Patients with Alopecia Areata: A Clinico-Histopathological Study
by: Hossam Anter, et al.
Published: (2023-02-01)

Immunopathogenesis of alopecia areata
by: Jadesola (Jadé) Temitope Olayinka, et al.
Published: (2021-01-01)

Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review
by: Ola Salhab, et al.
Published: (2022-10-01)

Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
by: Zhou J, et al.
Published: (2023-10-01)

Platelet Rich Plasma and Its Use in Hair Regrowth: A Review
by: Paichitrojjana A, et al.
Published: (2022-03-01)

Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
by: Kaelynn Workman, BS, et al.
Published: (2023-09-01)

Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
by: Weiyue Deng, et al.
Published: (2021-10-01)